Covid-19 Molecular Testing and Clinical Correlates, An Issue of the Clinics in Laboratory Medicine
- 1st Edition, Volume 42-2 - June 6, 2022
- Latest edition
- Editor: Sanjat Kanjilal
- Language: English
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular… Read more
Purchase options
In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular Testing and Clinical Correlates. Top experts in the field cover key topics such as point-of-care molecular assays for SARS-CoV-2; strategies for scaling up SARS-CoV-2 molecular testing capacity; cycle threshold values from SARS-CoV-2 PCR assays; and more.
-
Contains 12 relevant, practice-oriented topics including analytic and clinical performance of major commercial SARS-CoV-2 PCR assays in the United States; isothermal assays for SARS-CoV-2 detection; rapid antigen assays for SARS-CoV-2; approaches to deployment of molecular testing for SARS-CoV-2 in resource-limited settings; and more.
-
Provides in-depth clinical reviews on COVID-19 molecular testing and clinical correlates, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
SARS-CoV-2 Molecular Diagnostics in China
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings
Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States
An Overview of SARS-CoV-2 Molecular Diagnostics in Europe
SARS-CoV-2 Molecular Diagnostics in China
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2
Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases
Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2
Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity
Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings
Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
- Edition: 1
- Latest edition
- Volume: 42-2
- Published: June 6, 2022
- Language: English
SK
Sanjat Kanjilal
Affiliations and expertise
Associate Medical Director of Clinical Microbiology, Infectious Disease, Pathology, Brigham and Women's Hospital